5-HT receptor agonist-antagonist binding affinity ratios as a measure of intrinsic activity, using [3H]8-OH-DPAT and [3H]MPPF as radioligands

被引：0
|
作者：
Price, GW [1 ]
Ho, M [1 ]
Scott, C [1 ]
Selkirk, JV [1 ]
Brown, AM [1 ]
机构：
[1] SmithKline Beecham Pharmaceut, Dept Neurosci, NFSP, Harlow CM19 5AW, Essex, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1998年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
58P
引用
收藏
页码：U30 / U30
页数：1
相关论文
共 50 条
  • [21] Binding characteristics of [3H]14-methoxymetopon, a high affinity μ-opioid receptor agonist
    Spetea, M
    Tóth, F
    Schütz, J
    Ötvös, F
    Tóth, G
    Benyhe, S
    Borsodi, A
    Schmidhammer, H
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (02) : 290 - 295
  • [22] APPARENT REGIONAL DIFFERENCES IN 5-HT(1A) BINDING MAY REFLECT [H-3] 8-OH-DPAT LABELING OF SEROTONIN UPTAKE SITES
    SPROUSE, JS
    MCCARTY, DR
    DUDLEY, MW
    [J]. BRAIN RESEARCH, 1993, 617 (01) : 159 - 162
  • [23] Boost of imipramine acute antidepressant activity by SAM is not related with [3H]-8OH-DPAT binding to 5-HT1A receptors in rat hippocampus membranes
    Bellido, I
    Gomez, A
    Pages, C
    de la Cuesta, FS
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R36 - R36
  • [24] Pharmacological differences of [3H]citalopram binding to the 5-HT transporter among animal species
    Faedo, S.
    Negri, M.
    Wren, P. B.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 142 - 142
  • [25] Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat
    Eltayb, A
    Lindblom, S
    Oerther, S
    Ahlenius, S
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 2001, 172 (03): : 205 - 209
  • [26] Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist
    Jerning, E
    Svantesson, GT
    Mohell, N
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 360 (2-3) : 219 - 225
  • [27] Autoradiographic localisation of 5-HT4 receptors in the rat and human brain using two new radioligands:: [3H]prucalopride and [3H]R116712
    Langlois, X
    Bonaventure, P
    Riele, PT
    Wintmolders, C
    Hall, H
    Leysen, JE
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R113 - R113
  • [28] Human cerebral 5-HT2A receptor labelling with [18F]altanserin, [3H]LSD, and [3H]M100907. Relevance of radiotracer intrinsic activity
    Diez-Alarcia, R.
    Muguruza, C.
    Rivero, G.
    Garcia-Bea, A.
    Callado, L. F.
    Martin, A.
    Llop, J.
    Meana, J. J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S324 - S324
  • [29] EFFECT OF 5-HT(3)/5-HT(4) RECEPTOR LIGANDS ON IN-VITRO K+-STIMULATED [3H]5-HT RELEASE FROM RAT CORTICAL SLICES
    CHENG, CHK
    COSTALL, B
    MASON, K
    NAYLOR, RJ
    RUDD, JA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 : P133 - P133
  • [30] MOLECULAR PHARMACOLOGY OF 5-HT1 AND 5-HT2 RECOGNITION SITES IN RAT AND PIG BRAIN MEMBRANES - RADIOLIGAND BINDING-STUDIES WITH [H-3] 5-HT, [H-3] 8-OH-DPAT, (-) [I-125] IODOCYANOPINDOLOL, [H-3] MESULERGINE AND [H-3] KETANSERIN
    HOYER, D
    ENGEL, G
    KALKMAN, HO
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (1-2) : 13 - 23
12345